STN: 125770
Proper Name: Meningococcal Groups A, B, C, W, and Y Vaccine
Tradename: PENBRAYA
Manufacturer: Pfizer Ireland Pharmaceuticals
Indication:

• PENBRAYA is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y. PENBRAYA is approved for use in individuals 10 through 25 years of age.

Product Information

• Package Insert - PENBRAYA

Supporting Documents

• October 20, 2023 Approval Letter - PENBRAYA